PULSE BIOSCIENCES, INC. — Director's Dealing 2019

Jan 9, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2019-01-07

Reporting Person: Zanganeh Maky (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-01-07	Stock Option (right to buy)	$13.22	A	2364	Acquired	2029-01-07	Common Stock (2364)	Direct

Footnotes

F1: The shares subject to the option will fully vest on the date of the Issuer's Annual Meeting to be held in 2019, subject to the Reporting Person's continued service through such vesting date.